Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ADA Food & Nutrition Conference In Brief

This article was originally published in The Tan Sheet

Executive Summary

PBM formulas: Firm, which licenses rights to Wyeth's private label infant formula in the U.S., announces late-October launch of powdered formula fortified with docosahexaenoic, arachidonic acids under Wal-Mart Parent's Choice label at American Dietetic Association Food & Nutrition Conference in Philadelphia Oct. 20-22. Product comes in 31.7 oz., 14.1 oz. cans retailing for $16.88 and $8.93, respectively. Promotional materials state "Wal-Mart is honored to introduce the first affordable DHA/ARA-enriched formula"...

You may also be interested in...

NACDS Nutritionals In Brief

Rexall Sundown extensions: Carb Solutions milk chocolate, milk chocolate with almonds bars for individuals on low-carb diets to be supported by $11 mil. ad spend in 2003, with possible budget increase due to "dynamic" nature of bar category, Royal Numico subsidiary announces at National Association of Chain Drug Stores Marketplace Conference in San Diego June 16-18. Launching at mass and specialty outlets in late September, bars will retail for roughly $1.79. Met-Rx Protein Complete Bars for energy boost, RTD 25 protein shakes also debuting in September. Bars will be sold in cinnamon crunch, chocolate peanut roast, double chocolate fudge flavors for $1.79 each. Eleven ounce shakes in chocolate, strawberry and vanilla deliver 25 g protein. Four-can package will retail for $8.99-$9.99...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts